Home » Topics » Regulatory » NMPA

NMPA
RSS

CFDA grants approval for clinical trials of fadanafil

Dec. 16, 2016

No Comments

CFDA accepts CStone Pharmaceuticals' IND for anti-PD-L1 monoclonal antibody

Oct. 21, 2016

No Comments

BeiGene cleared to conduct clinical trials of BGB-A317 in China

Sep. 12, 2016

No Comments

Chinese clinical trial authorization for TaiGen's furaprevir

Aug. 19, 2016

No Comments

BioNano Genomics and Berry Genomics to codevelop next-generation mapping system

Aug. 18, 2016

No Comments

Cervarix approved in China

July 18, 2016

No Comments

CFDA approves Roche's CINtec PLUS Cytology test

March 9, 2016

No Comments

3SBio obtains IND clearance in China for PEG-irinotecan

March 7, 2016

No Comments

Tapros approved for open-angle glaucoma and ocular hypertension in China

Aug. 26, 2015

No Comments

CFDA approves phase I/II/III clinical trials of pirotinib

Aug. 14, 2015

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

NMPA
RSS

CFDA grants approval for clinical trials of fadanafil

CFDA accepts CStone Pharmaceuticals' IND for anti-PD-L1 monoclonal antibody

BeiGene cleared to conduct clinical trials of BGB-A317 in China

Chinese clinical trial authorization for TaiGen's furaprevir

BioNano Genomics and Berry Genomics to codevelop next-generation mapping system

Cervarix approved in China

CFDA approves Roche's CINtec PLUS Cytology test

3SBio obtains IND clearance in China for PEG-irinotecan

Tapros approved for open-angle glaucoma and ocular hypertension in China

CFDA approves phase I/II/III clinical trials of pirotinib

Today's news in brief

Today's news in brief

J&J’s Ottava robotic system approved for US pivotal trial

‘Evo’ AI can design complete genomes

Medtronic receives CE mark for next generation Endoflip system

NMPA RSS

NMPA
RSS